Trial Profile

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Safety and Efficacy of ABT-981 to Placebo in Subjects With Erosive Hand Osteoarthritis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Dec 2018 Results assessing efficcay and safety published in the Annals of the Rheumatic Diseases.
08 Nov 2017 Results assessing the efficacy and safety of ABT-981 in EHOA, were presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
17 Jun 2017 Primary endpoint (Change in pain as assessed by the Australian/Canadian Osteoarthritis Hand Index (AUSCAN NR3.1) pain subdomain score) has not been met, according to results presented at the 18th Annual Congress of the European League Against Rheumatism.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com